國泰君安(02611.HK)擬成立產業投資基金 聚焦醫療健康戰略投資
格隆匯 10 月 28日丨國泰君安(02611.HK)公告,於2020年10月28日,公司已通過母基金與國際集團(公司主要股東)及其他第三方訂立合夥協議,以成立預期規模為人民幣90億元,且首期認購結束時不少於人民幣70億元產業投資基金,旨在實施母基金聚焦於醫療健康產業的戰略投資計劃。
母基金已同意認繳(以孰低者為準):(a)人民幣16億元,即母基金合夥協議中允許母基金投資單個基金的最高額;或(b)該基金認購總額20%的該基金份額。在首期認購中,母基金擬認繳出資額為人民幣14億元,不超過該基金首期認購規模人民幣70億元20%。
倘該基金總規模在後續認購過程中達到人民幣90億元,則母基金認繳出資額將增加至人民幣16億元。國際集團已同意認繳人民幣5億元該基金份額。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.